Reprab Study: PLD + Trabectedin Rechallenge

Clinical trial NCT04887961 · UNKNOWN

Trial details

NCT number: NCT04887961
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Ovarian Cancer

Start date: 2020-10-01
Primary completion: 2022-04-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.